Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Author Correction: The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT).

Lu R, O'Rourke JJ, Sobinoff AP, Allen JAM, Nelson CB, Tomlinson CG, Lee M, Reddel RR, Deans AJ, Pickett HA.

Nat Commun. 2019 Nov 20;10(1):5345. doi: 10.1038/s41467-019-13097-2.

PMID:
31745078
2.

Addressing the Challenges of High-Throughput Cancer Tissue Proteomics for Clinical Application: ProCan.

Tully B, Balleine RL, Hains PG, Zhong Q, Reddel RR, Robinson PJ.

Proteomics. 2019 Nov;19(21-22):e1900109. doi: 10.1002/pmic.201900109. Epub 2019 Sep 24.

PMID:
31321850
3.

The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT).

Lu R, O'Rourke JJ, Sobinoff AP, Allen JAM, Nelson CB, Tomlinson CG, Lee M, Reddel RR, Deans AJ, Pickett HA.

Nat Commun. 2019 May 28;10(1):2252. doi: 10.1038/s41467-019-10180-6. Erratum in: Nat Commun. 2019 Nov 20;10(1):5345.

4.

Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency.

Han M, Napier CE, Frölich S, Teber E, Wong T, Noble JR, Choi EHY, Everett RD, Cesare AJ, Reddel RR.

J Cell Sci. 2019 Mar 14;132(5). pii: jcs222349. doi: 10.1242/jcs.222349.

5.

Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes.

Mehta SY, Morten BC, Antony J, Henderson L, Lasham A, Campbell H, Cunliffe H, Horsfield JA, Reddel RR, Avery-Kiejda KA, Print CG, Braithwaite AW.

Oncotarget. 2018 Jun 26;9(49):29146-29161. doi: 10.18632/oncotarget.25635. eCollection 2018 Jun 26.

6.

Telomere sequence content can be used to determine ALT activity in tumours.

Lee M, Teber ET, Holmes O, Nones K, Patch AM, Dagg RA, Lau LMS, Lee JH, Napier CE, Arthur JW, Grimmond SM, Hayward NK, Johansson PA, Mann GJ, Scolyer RA, Wilmott JS, Reddel RR, Pearson JV, Waddell N, Pickett HA.

Nucleic Acids Res. 2018 Jun 1;46(10):4903-4918. doi: 10.1093/nar/gky297.

7.

Functional dissection of breast cancer risk-associated TERT promoter variants.

Helbig S, Wockner L, Bouendeu A, Hille-Betz U, McCue K, French JD, Edwards SL, Pickett HA, Reddel RR, Chenevix-Trench G, Dörk T, Beesley J.

Oncotarget. 2017 May 26;8(40):67203-67217. doi: 10.18632/oncotarget.18226. eCollection 2017 Sep 15.

8.

Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours.

Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MCJ, Bruxner TJC, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Hiriyur Nagaraj S, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Vittoria Davì M, Landoni L, Malpaga A, Miotto M, Whitehall VLJ, Leggett BA, Harris JL, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagrial AM, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Barbour A, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras MC, Fisher WE, Dagg RA, Lau LMS, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Van Buren G, Partelli S, Fassan M; Australian Pancreatic Cancer Genome Initiative, Khanna KK, Gill AJ, Wheeler DA, Gibbs RA, Musgrove EA, Bassi C, Tortora G, Pederzoli P, Pearson JV, Waddell N, Biankin AV, Grimmond SM.

Nature. 2017 Oct 26;550(7677):548. doi: 10.1038/nature24026. Epub 2017 Sep 27.

PMID:
28953865
9.

BLM and SLX4 play opposing roles in recombination-dependent replication at human telomeres.

Sobinoff AP, Allen JA, Neumann AA, Yang SF, Walsh ME, Henson JD, Reddel RR, Pickett HA.

EMBO J. 2017 Oct 2;36(19):2907-2919. doi: 10.15252/embj.201796889. Epub 2017 Sep 6.

10.

MatCol: a tool to measure fluorescence signal colocalisation in biological systems.

Khushi M, Napier CE, Smyth CM, Reddel RR, Arthur JW.

Sci Rep. 2017 Aug 21;7(1):8879. doi: 10.1038/s41598-017-08786-1.

11.

Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres.

Dagg RA, Pickett HA, Neumann AA, Napier CE, Henson JD, Teber ET, Arthur JW, Reynolds CP, Murray J, Haber M, Sobinoff AP, Lau LMS, Reddel RR.

Cell Rep. 2017 Jun 20;19(12):2544-2556. doi: 10.1016/j.celrep.2017.05.087.

12.

Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences.

Yu Y, Katiyar SP, Sundar D, Kaul Z, Miyako E, Zhang Z, Kaul SC, Reddel RR, Wadhwa R.

Cell Death Dis. 2017 Apr 20;8(4):e2755. doi: 10.1038/cddis.2017.33.

13.

Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency.

Ginn SL, Hallwirth CV, Liao SH, Teber ET, Arthur JW, Wu J, Lee HC, Tay SS, Hu M, Reddel RR, McCormack MP, Thrasher AJ, Cavazzana M, Alexander SI, Alexander IE.

Mol Ther Nucleic Acids. 2017 Mar 17;6:1-14. doi: 10.1016/j.omtn.2016.11.011. Epub 2016 Dec 10.

14.

Whole-genome landscape of pancreatic neuroendocrine tumours.

Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Nagaraj SH, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Davì MV, Landoni L, Malpaga A, Miotto M, Whitehall VL, Leggett BA, Harris JL, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagrial AM, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Barbour A, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras MC, Fisher WE, Dagg RA, Lau LM, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Van Buren G, Partelli S, Fassan M; Australian Pancreatic Cancer Genome Initiative, Khanna KK, Gill AJ, Wheeler DA, Gibbs RA, Musgrove EA, Bassi C, Tortora G, Pederzoli P, Pearson JV, Waddell N, Biankin AV, Grimmond SM.

Nature. 2017 Mar 2;543(7643):65-71. doi: 10.1038/nature21063. Epub 2017 Feb 15. Erratum in: Nature. 2017 Sep 27;:.

PMID:
28199314
15.

DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.

Novakovic B, Napier CE, Vryer R, Dimitriadis E, Manuelpillai U, Sharkey A, Craig JM, Reddel RR, Saffery R.

Mol Hum Reprod. 2016 Nov;22(11):791-799. Epub 2016 Sep 7.

PMID:
27604461
16.

The C-Circle Assay for alternative-lengthening-of-telomeres activity.

Henson JD, Lau LM, Koch S, Martin La Rotta N, Dagg RA, Reddel RR.

Methods. 2017 Feb 1;114:74-84. doi: 10.1016/j.ymeth.2016.08.016. Epub 2016 Sep 3.

PMID:
27595911
17.

Comparative analysis of whole genome sequencing-based telomere length measurement techniques.

Lee M, Napier CE, Yang SF, Arthur JW, Reddel RR, Pickett HA.

Methods. 2017 Feb 1;114:4-15. doi: 10.1016/j.ymeth.2016.08.008. Epub 2016 Aug 24.

PMID:
27565742
18.

Molecular mechanisms of activity and derepression of alternative lengthening of telomeres.

Pickett HA, Reddel RR.

Nat Struct Mol Biol. 2015 Nov;22(11):875-80. doi: 10.1038/nsmb.3106. Epub 2015 Nov 4. Review.

PMID:
26581522
19.

Is cell culture a risky business? Risk analysis based on scientist survey data.

Shannon M, Capes-Davis A, Eggington E, Georghiou R, Huschtscha LI, Moy E, Power M, Reddel RR, Arthur JW.

Int J Cancer. 2016 Feb 1;138(3):664-70. doi: 10.1002/ijc.29817. Epub 2015 Sep 14.

20.

The wide-ranging clinical implications of the short telomere syndromes.

Barbaro PM, Ziegler DS, Reddel RR.

Intern Med J. 2016 Apr;46(4):393-403. doi: 10.1111/imj.12868. Review.

PMID:
26247919
21.

A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase.

Killedar A, Stutz MD, Sobinoff AP, Tomlinson CG, Bryan TM, Beesley J, Chenevix-Trench G, Reddel RR, Pickett HA.

PLoS Genet. 2015 Jun 8;11(6):e1005286. doi: 10.1371/journal.pgen.1005286. eCollection 2015 Jun.

22.

ATRX represses alternative lengthening of telomeres.

Napier CE, Huschtscha LI, Harvey A, Bower K, Noble JR, Hendrickson EA, Reddel RR.

Oncotarget. 2015 Jun 30;6(18):16543-58.

23.

Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis.

Locke WJ, Zotenko E, Stirzaker C, Robinson MD, Hinshelwood RA, Stone A, Reddel RR, Huschtscha LI, Clark SJ.

Clin Epigenetics. 2015 May 1;7:52. doi: 10.1186/s13148-015-0086-0. eCollection 2015.

24.

STC1 expression is associated with tumor growth and metastasis in breast cancer.

Chang AC, Doherty J, Huschtscha LI, Redvers R, Restall C, Reddel RR, Anderson RL.

Clin Exp Metastasis. 2015 Jan;32(1):15-27. doi: 10.1007/s10585-014-9687-9. Epub 2014 Nov 13.

PMID:
25391215
25.

Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1.

Guo Y, Kartawinata M, Li J, Pickett HA, Teo J, Kilo T, Barbaro PM, Keating B, Chen Y, Tian L, Al-Odaib A, Reddel RR, Christodoulou J, Xu X, Hakonarson H, Bryan TM.

Blood. 2014 Oct 30;124(18):2767-74. doi: 10.1182/blood-2014-08-596445. Epub 2014 Sep 9.

26.

NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.

Conomos D, Reddel RR, Pickett HA.

Nat Struct Mol Biol. 2014 Sep;21(9):760-70. doi: 10.1038/nsmb.2877. Epub 2014 Aug 24.

PMID:
25150861
27.

Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A.

Gupta R, Dong Y, Solomon PD, Wettersten HI, Cheng CJ, Min JN, Henson J, Dogra SK, Hwang SH, Hammock BD, Zhu LJ, Reddel RR, Saltzman WM, Weiss RH, Chang S, Green MR, Wajapeyee N.

Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3062-71. doi: 10.1073/pnas.1411370111. Epub 2014 Jul 14.

28.

Telomere maintenance mechanisms in cancer: clinical implications.

Reddel RR.

Curr Pharm Des. 2014;20(41):6361-74. Review.

29.

Molecular characterization of collaborator of ARF (CARF) as a DNA damage response and cell cycle checkpoint regulatory protein.

Singh R, Kalra RS, Hasan K, Kaul Z, Cheung CT, Huschtscha L, Reddel RR, Kaul SC, Wadhwa R.

Exp Cell Res. 2014 Apr 1;322(2):324-34. doi: 10.1016/j.yexcr.2014.01.022. Epub 2014 Jan 28.

PMID:
24485912
30.

Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes.

Lee M, Hills M, Conomos D, Stutz MD, Dagg RA, Lau LM, Reddel RR, Pickett HA.

Nucleic Acids Res. 2014 Feb;42(3):1733-46. doi: 10.1093/nar/gkt1117. Epub 2013 Nov 12.

31.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.

Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, Baynes C, Bolla MK, Wang Q, Dennis J, McGuffog L, Barrowdale D, Lee A, Healey S, Lush M, Tessier DC, Vincent D, Bacot F; Australian Cancer Study; Australian Ovarian Cancer Study; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab); Gene Environment Interaction and Breast Cancer (GENICA); Swedish Breast Cancer Study (SWE-BRCA); Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE); Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO), Vergote I, Lambrechts S, Despierre E, Risch HA, González-Neira A, Rossing MA, Pita G, Doherty JA, Alvarez N, Larson MC, Fridley BL, Schoof N, Chang-Claude J, Cicek MS, Peto J, Kalli KR, Broeks A, Armasu SM, Schmidt MK, Braaf LM, Winterhoff B, Nevanlinna H, Konecny GE, Lambrechts D, Rogmann L, Guénel P, Teoman A, Milne RL, Garcia JJ, Cox A, Shridhar V, Burwinkel B, Marme F, Hein R, Sawyer EJ, Haiman CA, Wang-Gohrke S, Andrulis IL, Moysich KB, Hopper JL, Odunsi K, Lindblom A, Giles GG, Brenner H, Simard J, Lurie G, Fasching PA, Carney ME, Radice P, Wilkens LR, Swerdlow A, Goodman MT, Brauch H, Garcia-Closas M, Hillemanns P, Winqvist R, Dürst M, Devilee P, Runnebaum I, Jakubowska A, Lubinski J, Mannermaa A, Butzow R, Bogdanova NV, Dörk T, Pelttari LM, Zheng W, Leminen A, Anton-Culver H, Bunker CH, Kristensen V, Ness RB, Muir K, Edwards R, Meindl A, Heitz F, Matsuo K, du Bois A, Wu AH, Harter P, Teo SH, Schwaab I, Shu XO, Blot W, Hosono S, Kang D, Nakanishi T, Hartman M, Yatabe Y, Hamann U, Karlan BY, Sangrajrang S, Kjaer SK, Gaborieau V, Jensen A, Eccles D, Høgdall E, Shen CY, Brown J, Woo YL, Shah M, Azmi MA, Luben R, Omar SZ, Czene K, Vierkant RA, Nordestgaard BG, Flyger H, Vachon C, Olson JE, Wang X, Levine DA, Rudolph A, Weber RP, Flesch-Janys D, Iversen E, Nickels S, Schildkraut JM, Silva Idos S, Cramer DW, Gibson L, Terry KL, Fletcher O, Vitonis AF, van der Schoot CE, Poole EM, Hogervorst FB, Tworoger SS, Liu J, Bandera EV, Li J, Olson SH, Humphreys K, Orlow I, Blomqvist C, Rodriguez-Rodriguez L, Aittomäki K, Salvesen HB, Muranen TA, Wik E, Brouwers B, Krakstad C, Wauters E, Halle MK, Wildiers H, Kiemeney LA, Mulot C, Aben KK, Laurent-Puig P, Altena AM, Truong T, Massuger LF, Benitez J, Pejovic T, Perez JI, Hoatlin M, Zamora MP, Cook LS, Balasubramanian SP, Kelemen LE, Schneeweiss A, Le ND, Sohn C, Brooks-Wilson A, Tomlinson I, Kerin MJ, Miller N, Cybulski C, Henderson BE, Menkiszak J, Schumacher F, Wentzensen N, Le Marchand L, Yang HP, Mulligan AM, Glendon G, Engelholm SA, Knight JA, Høgdall CK, Apicella C, Gore M, Tsimiklis H, Song H, Southey MC, Jager A, den Ouweland AM, Brown R, Martens JW, Flanagan JM, Kriege M, Paul J, Margolin S, Siddiqui N, Severi G, Whittemore AS, Baglietto L, McGuire V, Stegmaier C, Sieh W, Müller H, Arndt V, Labrèche F, Gao YT, Goldberg MS, Yang G, Dumont M, McLaughlin JR, Hartmann A, Ekici AB, Beckmann MW, Phelan CM, Lux MP, Permuth-Wey J, Peissel B, Sellers TA, Ficarazzi F, Barile M, Ziogas A, Ashworth A, Gentry-Maharaj A, Jones M, Ramus SJ, Orr N, Menon U, Pearce CL, Brüning T, Pike MC, Ko YD, Lissowska J, Figueroa J, Kupryjanczyk J, Chanock SJ, Dansonka-Mieszkowska A, Jukkola-Vuorinen A, Rzepecka IK, Pylkäs K, Bidzinski M, Kauppila S, Hollestelle A, Seynaeve C, Tollenaar RA, Durda K, Jaworska K, Hartikainen JM, Kosma VM, Kataja V, Antonenkova NN, Long J, Shrubsole M, Deming-Halverson S, Lophatananon A, Siriwanarangsan P, Stewart-Brown S, Ditsch N, Lichtner P, Schmutzler RK, Ito H, Iwata H, Tajima K, Tseng CC, Stram DO, van den Berg D, Yip CH, Ikram MK, Teh YC, Cai H, Lu W, Signorello LB, Cai Q, Noh DY, Yoo KY, Miao H, Iau PT, Teo YY, McKay J, Shapiro C, Ademuyiwa F, Fountzilas G, Hsiung CN, Yu JC, Hou MF, Healey CS, Luccarini C, Peock S, Stoppa-Lyonnet D, Peterlongo P, Rebbeck TR, Piedmonte M, Singer CF, Friedman E, Thomassen M, Offit K, Hansen TV, Neuhausen SL, Szabo CI, Blanco I, Garber J, Narod SA, Weitzel JN, Montagna M, Olah E, Godwin AK, Yannoukakos D, Goldgar DE, Caldes T, Imyanitov EN, Tihomirova L, Arun BK, Campbell I, Mensenkamp AR, van Asperen CJ, van Roozendaal KE, Meijers-Heijboer H, Collée JM, Oosterwijk JC, Hooning MJ, Rookus MA, van der Luijt RB, Os TA, Evans DG, Frost D, Fineberg E, Barwell J, Walker L, Kennedy MJ, Platte R, Davidson R, Ellis SD, Cole T, Bressac-de Paillerets B, Buecher B, Damiola F, Faivre L, Frenay M, Sinilnikova OM, Caron O, Giraud S, Mazoyer S, Bonadona V, Caux-Moncoutier V, Toloczko-Grabarek A, Gronwald J, Byrski T, Spurdle AB, Bonanni B, Zaffaroni D, Giannini G, Bernard L, Dolcetti R, Manoukian S, Arnold N, Engel C, Deissler H, Rhiem K, Niederacher D, Plendl H, Sutter C, Wappenschmidt B, Borg A, Melin B, Rantala J, Soller M, Nathanson KL, Domchek SM, Rodriguez GC, Salani R, Kaulich DG, Tea MK, Paluch SS, Laitman Y, Skytte AB, Kruse TA, Jensen UB, Robson M, Gerdes AM, Ejlertsen B, Foretova L, Savage SA, Lester J, Soucy P, Kuchenbaecker KB, Olswold C, Cunningham JM, Slager S, Pankratz VS, Dicks E, Lakhani SR, Couch FJ, Hall P, Monteiro AN, Gayther SA, Pharoah PD, Reddel RR, Goode EL, Greene MH, Easton DF, Berchuck A, Antoniou AC, Chenevix-Trench G, Dunning AM.

Nat Genet. 2013 Apr;45(4):371-84, 384e1-2. doi: 10.1038/ng.2566.

32.

Alternative lengthening of telomeres: remodeling the telomere architecture.

Conomos D, Pickett HA, Reddel RR.

Front Oncol. 2013 Feb 20;3:27. doi: 10.3389/fonc.2013.00027. eCollection 2013.

33.

Alternative lengthening of telomeres in normal mammalian somatic cells.

Neumann AA, Watson CM, Noble JR, Pickett HA, Tam PP, Reddel RR.

Genes Dev. 2013 Jan 1;27(1):18-23. doi: 10.1101/gad.205062.112.

34.

STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer.

Peña C, Céspedes MV, Lindh MB, Kiflemariam S, Mezheyeuski A, Edqvist PH, Hägglöf C, Birgisson H, Bojmar L, Jirström K, Sandström P, Olsson E, Veerla S, Gallardo A, Sjöblom T, Chang AC, Reddel RR, Mangues R, Augsten M, Ostman A.

Cancer Res. 2013 Feb 15;73(4):1287-97. doi: 10.1158/0008-5472.CAN-12-1875. Epub 2012 Dec 14.

35.

Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells.

Conomos D, Stutz MD, Hills M, Neumann AA, Bryan TM, Reddel RR, Pickett HA.

J Cell Biol. 2012 Dec 10;199(6):893-906. doi: 10.1083/jcb.201207189.

36.

Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres.

Bower K, Napier CE, Cole SL, Dagg RA, Lau LM, Duncan EL, Moy EL, Reddel RR.

PLoS One. 2012;7(11):e50062. doi: 10.1371/journal.pone.0050062. Epub 2012 Nov 20.

37.

Stanniocalcin 1 is important for poststroke functionality, but dispensable for ischemic tolerance.

Durukan Tolvanen A, Westberg JA, Serlachius M, Chang AC, Reddel RR, Andersson LC, Tatlisumak T.

Neuroscience. 2013 Jan 15;229:49-54. doi: 10.1016/j.neuroscience.2012.10.062. Epub 2012 Nov 14.

PMID:
23159313
38.

Extreme telomere length dimorphism in the Tasmanian devil and related marsupials suggests parental control of telomere length.

Bender HS, Murchison EP, Pickett HA, Deakin JE, Strong MA, Conlan C, McMillan DA, Neumann AA, Greider CW, Hannon GJ, Reddel RR, Graves JA.

PLoS One. 2012;7(9):e46195. doi: 10.1371/journal.pone.0046195. Epub 2012 Sep 25.

39.

Enhanced isolation of fibroblasts from human skin explants.

Huschtscha LI, Napier CE, Noble JR, Bower K, Au AY, Campbell HG, Braithwaite AW, Reddel RR.

Biotechniques. 2012 Oct;53(4):239-44. doi: 10.2144/0000113939.

40.

Detection of alternative lengthening of telomeres by telomere quantitative PCR.

Lau LM, Dagg RA, Henson JD, Au AY, Royds JA, Reddel RR.

Nucleic Acids Res. 2013 Jan;41(2):e34. doi: 10.1093/nar/gks781. Epub 2012 Aug 25.

41.

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.

Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JH, Sung PA, Jasin M, Rosenbluh J, Zwang Y, Weir BA, Hatton C, Ivanova E, Macconaill L, Hanna M, Hahn WC, Lue NF, Reddel RR, Jiao Y, Kinzler K, Vogelstein B, Papadopoulos N, Meeker AK; ALT Starr Cancer Consortium.

PLoS Genet. 2012;8(7):e1002772. Epub 2012 Jul 19.

42.

Cancer. Cancer and telomeres--an ALTernative to telomerase.

Shay JW, Reddel RR, Wright WE.

Science. 2012 Jun 15;336(6087):1388-90. doi: 10.1126/science.1222394. No abstract available.

PMID:
22700908
43.

The role of telomere trimming in normal telomere length dynamics.

Pickett HA, Reddel RR.

Cell Cycle. 2012 Apr 1;11(7):1309-15. doi: 10.4161/cc.19632. Epub 2012 Apr 1. Review.

PMID:
22421147
44.

Five dysfunctional telomeres predict onset of senescence in human cells.

Kaul Z, Cesare AJ, Huschtscha LI, Neumann AA, Reddel RR.

EMBO Rep. 2011 Dec 23;13(1):52-9. doi: 10.1038/embor.2011.227.

45.

Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers.

Beesley J, Pickett HA, Johnatty SE, Dunning AM, Chen X, Li J, Michailidou K, Lu Y, Rider DN, Palmieri RT, Stutz MD, Lambrechts D, Despierre E, Lambrechts S, Vergote I, Chang-Claude J, Nickels S, Vrieling A, Flesch-Janys D, Wang-Gohrke S, Eilber U, Bogdanova N, Antonenkova N, Runnebaum IB, Dörk T, Goodman MT, Lurie G, Wilkens LR, Matsuno RK, Kiemeney LA, Aben KK, Marees T, Massuger LF, Fridley BL, Vierkant RA, Bandera EV, Olson SH, Orlow I, Rodriguez-Rodriguez L, Cook LS, Le ND, Brooks-Wilson A, Kelemen LE, Campbell I, Gayther SA, Ramus SJ, Gentry-Maharaj A, Menon U, Ahmed S, Baynes C, Pharoah PD; kConFab Investigators; Australian Ovarian Cancer Study Group; ABCTB Investigators, Muir K, Lophatananon A, Chaiwerawattana A, Wiangnon S, Macgregor S, Easton DF, Reddel RR, Goode EL, Chenevix-Trench G; Ovarian Cancer Association Consortium.

PLoS One. 2011;6(9):e24987. doi: 10.1371/journal.pone.0024987. Epub 2011 Sep 15.

46.

Normal mammalian cells negatively regulate telomere length by telomere trimming.

Pickett HA, Henson JD, Au AY, Neumann AA, Reddel RR.

Hum Mol Genet. 2011 Dec 1;20(23):4684-92. doi: 10.1093/hmg/ddr402. Epub 2011 Sep 8.

PMID:
21903669
47.

MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region.

Yoon AR, Gao R, Kaul Z, Choi IK, Ryu J, Noble JR, Kato Y, Saito S, Hirano T, Ishii T, Reddel RR, Yun CO, Kaul SC, Wadhwa R.

Nucleic Acids Res. 2011 Oct;39(18):8078-91. doi: 10.1093/nar/gkr492. Epub 2011 Jun 30.

48.

HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA but not ASF1a.

Jiang WQ, Nguyen A, Cao Y, Chang AC, Reddel RR.

PLoS One. 2011 Feb 15;6(2):e17036. doi: 10.1371/journal.pone.0017036.

49.

Telomerase activity in pleural malignant mesotheliomas.

Au AY, Hackl T, Yeager TR, Cohen SB, Pass HI, Harris CC, Reddel RR.

Lung Cancer. 2011 Sep;73(3):283-8. doi: 10.1016/j.lungcan.2010.12.023. Epub 2011 Jan 31.

50.

Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers.

Henson JD, Reddel RR.

FEBS Lett. 2010 Sep 10;584(17):3800-11. doi: 10.1016/j.febslet.2010.06.009. Epub 2010 Jun 11. Review.

Supplemental Content

Loading ...
Support Center